Acute Seizures and Status Epilepticus in Infants and Children - Paediatric Intensive Care Unit, Leeds Children’s Hospital
|Last review: 03/01/2018|
|Next review: 03/01/2021|
|Copyright© Leeds Teaching Hospitals NHS Trust 2018|
This Clinical Guideline is intended for use by healthcare professionals within Leeds unless otherwise stated.
Guideline for Management of Acute Seizures and Status Epilepticus in Infants and Children
Paediatric Intensive Care Unit, Leeds Children’s Hospital
- Aetiology of status epilepticus in children
- Systemic complications
- Initial management
- Basic investigations
- Further investigations
- Management of refactory status epilepticus
- Antibiotics and antivirals
This document is aimed at medical and nursing staff on the Paediatric Intensive Care Unit (PICU) looking after patients with acute seizures who are referred or admitted to the PICU. It should be used for management of prolonged (or repetitive) generalised or focal, clonic or tonic-clonic seizures. The treatment of any other type of seizure should be discussed with a consultant paediatric neurologist.
Convulsive status epilepticus is a life threatening condition with serious risk of neurological sequelae or death. The reported mortality rates of status epilepticus in children vary from 3 to 9%, with underlying aetiology as the main predictor.
Convulsive status epilepticus (SE) is traditionally defined as a clonic or tonic-clonic seizure lasting more than 30 minutes, or repeated seizures occurring over a 30 minute period without recovery of consciousness between each convulsion. Some studies have suggested that the definition should include patients with seizures of a shorter duration, such as 10 minutes. For the purpose of treatment decisions, this shorter definition has merit. Convulsive seizures lasting more than 5 to 10 minutes have a higher risk of lasting 30 minutes or more, and treatment delay is associated with delayed response to treatment. Extensor posturing is a sign of brain herniation until proven otherwise.
Refractory SE is that which persists for longer than 60 minutes despite appropriate treatment with benzodiazepines, phenytoin and phenobarbitone. The outcome in terms of morbidity and mortality is worse with more prolonged seizures.
25% are complex febrile convulsions (this is usually a retrospective diagnosis)
25% are remote symptomatic (children with prior neurological abnormality)
25% are idiopathic epilepsy
25% are acute symptomatic requiring specific treatment
- Traumatic brain injury, including non accidental injury
- CNS infection: meningitis, encephalitis, cerebral abscess, empyema
- Encephalopathy: metabolic disease, poisoning, electrolyte disturbance
- Space occupying lesion (tumour, haematoma or blocked shunt)
- Acute hypoxic ischaemic insult
- Cerebrovascular event
- Sudden withdrawal of anti-epileptic drugs in child with epilepsy
These contribute to morbidity and mortality related to SE and include:
- Lactic acidosis or respiratory acidosis
- Hyperglycaemia or hypoglycaemia
- Blood pressure disturbances
- Raised intracranial pressure
- Rhabdomyolysis and acute kidney injury
- Follow initial APLS treatment algorithm (appendix 1)
- Treat hypoglycaemia
- If giving phenytoin monitor for hypotension and cardiac arrythmias
- Do basic investigations (section 7)
- Consider whether there may be an acute symptomatic aetiology which requires further investigation (section 8) and urgent treatment
- If still fitting at 40 minutes then call anaesthetist to intubate and ventilate
- Discuss with consultant paediatrician and PICU
- Blood sugar
- Blood pressure (to exclude hypertensive encephalopathy as primary cause)
- FBC, CRP, U&Es, calcium, magnesium, blood culture
- Check anti-epileptic drug levels if on treatment for epilepsy
Urgent CT brain may be needed to exclude space occupying lesions such as tumour, bleed or abscess. Ask for CT with contrast if meningitis or abscess is suspected. Remember that a normal CT scan does not rule out the possibility of raised intracranial pressure.
Arrange an urgent CT scan if any of the following are present:
- Any child with SE when aetiology is unknown
- Focal neurological signs including focal seizure
- Asymmetric or unreactive pupils
- Clinical suspicion of raised intracranial pressure
- Reduced conscious level 1 hour post seizure
- History of trauma
- Suspicion of non accidental head injury
Lumbar puncture is not necessary during acute stage and will not change immediate management. Send for MC&S, protein, glucose, meningococcal PCR and herpes PCR. Don’t forget to do blood glucose at the same time.
Indications for LP
- age <12 months
- suspicion of meningitis or encephalitis; consider LP in all children presenting with first episode of febrile convulsive status epilepticus
Relative contradindications to LP *
- Glasgow Coma Score <13
- Other signs of raised intracranial pressure (altered pupillary responses, absent Doll’s eye reflexes, decerebrate or decorticate posturing, abnormal respiratory pattern, papilloedema, hypertension, bradycardia)
- Within 30 minutes of a convulsive seizure
- Focal seizures or new focal neurological signs
- Tonic seizures (beware extensor posturing - this is a sign of brain herniation until proven otherwise)
- Clinical evidence of systemic meningococcal disease or shock
- Local infection over the LP site
- Coagulopathy, low platelet count or anticoagulant treatment
* If a relative contraindication is present, LP should not be undertaken without discussion with a PICU consultant.
EEG should be requested if there is:
- Unexplained SE in any child
- Refractory SE
- Focal seizures
- Possible non convulsive status or sub clinical status epilepticus
Other investigations to consider:
- Mycoplasma serology (acute and convalescent)
- Viral serology
- Urine toxicology
- Metabolic investigations (consider if history of consanguinity, or previous family history of metabolic disease or unexplained death. If high suspicion then discuss at an early stage with a metabolic consultant or a paediatric neurologist).
- Blood gas
- Biotinidase level
- Serum ammonia and lactate
- Urine amino acids and organic acids, serum amino acids
- Discuss with consultant paediatric intensivist and neurologist
- Consider continuous cerebral function monitoring
- IV phenobarbitone 20mg/kg loading dose. Infuse over 30 minutes
- IV midazolam. Start with a bolus of 100microgram/kg plus an infusion at 2microgram/kg/min. Reassess every 15 minutes. If no response then give a further bolus, before increasing by 2 microgram/kg/min. Repeat until response seen, up to a maximum of 20 microgram /kg/min.
- Consider IV levetiracetam 40mg/kg (dose approved by Drug and Therapeutics Group for patients aged 6 months to 18 years).
- IV thiopentone 4mg/kg bolus. Infusion dose 2-8 mg/kg/hr to induce burst suppression for 24 to 48 hours. Must be done with cerebral function monitoring and under consultant supervision. Patient may require inotropic support.
- For unexplained refractory SE in neonates and infants start pyridoxine 30mg/kg/day
- Consider folinic acid 5-15mg BD in neonates
- Consider biotin 10mg OD in neonates after discussion with a metabolic consultant or paediatric neurologist
Cefotaxime for any child in whom CNS infection cannot be excluded, all seizures >30 min, complex febrile seizures.
Have a low threshold for giving Aciclovir (for herpes simplex encephalitis) and Erythromycin (for mycoplasma encephalitis). Aciclovir should be given to any child with a first or unexplained febrile SE until herpes simplex encephalitis is excluded.
Aciclovir and erythromycin should both be added if:
- History of prodromal illness that may suggest encephalitis: fever, altered consciousness, behavioural changes, or history of recent herpes infection
- Focal neurological signs including focal seizures
- Any neonate (<28 days of age) presenting with seizure or reduced conscious level of unknown cause
Please refer to the BNF for children for guidance on drug dosing.
This document is aimed at medical and nursing staff on PICU looking after patients with acute seizures who are referred or admitted to the Paediatric Intensive Care Unit. It should be used for management of prolonged (or repetitive) generalised or focal, clonic or tonic-clonic seizures. The treatment of any other type of seizure should be discussed with a consultant paediatric neurologist.
Status epilepticus/acute seizure
|Target patient group:||Patients with acute seizures who are referred or admitted to the Paediatric Intensive Care Unit.|
|Target professional group(s):||Secondary Care Doctors
Secondary Care Nurses
- The Status Epilepticus Working Party. The treatment of convulsive status epilepticus in children. Arch Dis Child 2000; 83:415-419
- Advanced Life Support Group. Advanced Paediatric Life Support. A practical approach to emergencies. Sixth edition.
- McIntyre J et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005 Jul 16-22; 366 (9481): 182-3
- Baumer JH et al. Evidence based guideline for post seizure management in children presenting acutely to secondary care. Arch Dis Child 2004; 89:278-280
- Chin RFM et al. Meningitis is a common cause of convulsive status epilepticus with fever. Arch Dis Child 2005; 90: 66-69
- Allen J et al. Recovery of consciousness following epileptic seizures in children. Arch Dis Child 2007; 92: 39-42
- Appleton R et al. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2008 Jul 16; (3): CD001905
- Clinical features and complications of status epilepticus in children. www.uptodate.com Literature review current to November 2017
- Management of convulsive status epilepticus in children. www.uptodate.com Literature review current to November 2017
LHP version 1.0
Equity and Diversity
The Leeds Teaching Hospitals NHS Trust is committed to ensuring that the way that we provide services and the way we recruit and treat staff reflects individual needs, promotes equality and does not discriminate unfairly against any particular individual or group.